Evidence map›Paper›PMID 39156979›Full record

ArticleFarmaceuticos comunitarios2023

[May Measurement Month 2019: Screening Analysis In Spanish Community Pharmacies and Detection of Masked Hypertension].

Inés Mera-Gallego, Salvador Tous I Trepat, Rosa Prats-Mas, Ana Molinero, José Antonio Fornos-Pérez, N Floro Andrés-Rodríguez

Abstract readEnglish Abstract
In one paragraph

Article in Farmaceuticos comunitarios, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Inés Mera-GallegoMiembro del grupo de Diabetes de SEFAC Sociedad Española de Farmacia Clínica, Familiar y Comunitaria España.
Salvador Tous I TrepatMiembro del grupo de HTA y RV de SEFAC Sociedad Española de Farmacia Clínica, Familiar y Comunitaria España.
Rosa Prats-MasDoctora en Farmacia. Farmacéutica comunitaria en Denia (Alicante) España.
Ana MolineroDoctora en Farmacia. Miembro del grupo de HTA y RV de SEFAC Sociedad Española de Farmacia Clínica, Familiar y Comunitaria España.
José Antonio Fornos-PérezDoctor en Farmacia. Miembro del grupo de Diabetes de SEFAC. Profesor Asociado USC. Sociedad Española de Farmacia Clínica, Familiar y Comunitaria España.
N Floro Andrés-RodríguezDoctor en Farmacia. Miembro del grupo de Diabetes de SEFAC Sociedad Española de Farmacia Clínica, Familiar y Comunitaria España.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aim: To know within the scope of the May Measurement Month (MMM) project, the blood pressure (BP) situation in the Spanish population, disseminate the importance of its periodic measurement and estimate the prevalence of masked hypertension (MH). Methods: Transversal descriptive study in Spanish community pharmacies during May 2019. Variables: Systolic blood pressure (SBP), diastolic blood pressure (DBP) in millimetres of mercury (mmHg), heart rate (HR) in beats per minute (bpm).Subjects with BP ≥130/85 and <149/90 were offered the possibility of home blood pressure monitor- ing (HBPM) to confirm MH. Results: A total of 3402 valid records performed by 491 pharmacists. In all 61.9% women, mean age 56.6 years. A total of 143 (4.2%) had never measured BP and 918 (27.0%) had not measured BP in the last year; 1047 were taking anti-hypertensives, of whom 45.7% had high BP.A total of 780 (22.9%) subjects had high BP values; both, 252 (7.4%). mSBP and mDBP was 125.0 mmHg and 76.5 mmHg, respectively; higher in men (P<0.001). mHR was 72.6 bpm..A direct relationship was detected between SBP and DBP and BMI (P<0.0001). mSBP and mHR were higher in smokers (P<0.0001). In diabetic patients, SBP, DBP and HR were greater.A total of 61 subjects with suspected MH agreed to undergo HBPM. A total of 25 (40.1%) resulted in BP ≥135/85 mmHg. Conclusions: Almost a quarter of subjects had BP ≥140/90 mmHg. The risk factors most closely related to high BP were overweight, diabetes and age; 40% of suspected cases of MH were confirmed by means of HBPM.

Indexed as

blood pressurecommunity pharmacistshome Blood Pressure Monitoring (HBPM)hypertensionmasked hypertensionscreening

Identifiers

PMID39156979
PMCPMC11326689

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.